Boris Böll
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 50
- Oncology 48
- CAR-T cell therapy research 13
- Neutropenia and Cancer Infections 13
- Viral-associated cancers and disorders 11
- Co-authors
- Matthias Kochanek (43 shared papers)Alexander Shimabukuro‐Vornhagen (31 shared papers)Michael S. von Bergwelt‐Baildon (2 shared papers)Philipp Gödel (4 shared papers)Hans‐Joachim Stemmler (3 shared papers)Marion Subklewe (3 shared papers)Max Schlaak (1 shared paper)Hans Schlößer (1 shared paper)
- Journals
- Blood (26 papers)Journal of Clinical Oncology (6 papers)Annals of Hematology (5 papers)European Journal Of Haematology (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Boris Böll
106 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 1.5k
- Pathology and Forensic Medicine 879
- Neurology 662
- Infectious Diseases 751
- Immunology 732
Countries citing papers authored by Boris Böll
This map shows the geographic impact of Boris Böll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Böll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Böll more than expected).
Fields of papers citing papers by Boris Böll
This network shows the impact of papers produced by Boris Böll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Böll. The network helps show where Boris Böll may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Böll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytokine release syndrome Hit paper breakdown → | 2018 | 1161 |
| 2 | COVID‐19 associated pulmonary aspergillosis Hit paper breakdown → | 2020 | 401 |
| 3 | 2007 | 271 | |
| 4 | 2019 | 100 | |
| 5 | 2014 | 92 | |
| 6 | 2019 | 87 | |
| 7 | 2020 | 78 | |
| 8 | 2011 | 77 | |
| 9 | 2016 | 71 | |
| 10 | 2013 | 68 | |
| 11 | 2016 | 65 | |
| 12 | 2012 | 60 | |
| 13 | 2011 | 58 | |
| 14 | 2009 | 53 | |
| 15 | 2015 | 52 | |
| 16 | 2021 | 49 | |
| 17 | 2013 | 48 | |
| 18 | 2021 | 44 | |
| 19 | 2017 | 43 | |
| 20 | 2011 | 39 |
About Boris Böll
Boris Böll is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Epidemiology, having authored 123 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Lung Cancer Treatments and Mutations (24 papers), Chronic Lymphocytic Leukemia Research (19 papers), CAR-T cell therapy research (13 papers), Neutropenia and Cancer Infections (13 papers), Sepsis Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (11 papers) and Palliative Care and End-of-Life Issues (11 papers). The work is most often cited by research in Oncology (1.5k citations), Pathology and Forensic Medicine (879 citations), Neurology (662 citations), Infectious Diseases (751 citations) and Immunology (732 citations). Boris Böll has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Matthias Kochanek, Alexander Shimabukuro‐Vornhagen, Michael S. von Bergwelt‐Baildon, Philipp Gödel, Hans‐Joachim Stemmler, Marion Subklewe, Max Schlaak, Hans Schlößer, Dennis A. Eichenauer and Peter Borchmann. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, European Journal Of Haematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.